This comparative controlled clinical study was designed to evaluate the efficacy of Olanzapine with Chlorpromazine on the intensity of heroin withdrawal. This study included two groups of heroin dependents, each containing 30 subjects. One group receive Olanzapine and other was treated with Chlorpromazine, while same symptomatic treatment was given to both groups. Both groups were homogeneous in age, sex, social status, duration and quantity of heroin intake. Full study period was 21 days including 15 days as inpatients and 7 days as outpatients. Evaluation of withdrawal syndrome was performed by means of a rating scale including 12 parameters. Special attention was given to aches and pains, restlessness, craving for heroin, food intake, disturbance of sleep and agitation. Present study shows significant improvement in following areas with Olanzapineas as compared to Chlorpromazine, food intake 22 (73.3%) vs 10 (33.33%), sleep 15 (50%) vs 8 (26.6%), restlessness 21 (70%) vs 14 (46.6%), agitation 24 (80%) vs 13 (43.33%) and craving for heroin 20 (66.66%) vs 12 (40%) patients.